Literature DB >> 26106180

Post-transfusion breathlessness in a patient with acute myeloid leukaemia.

Arjun Gupta1, Kisan Parikh1, Ambarish Pandey1.   

Abstract

We present a case of a 38-year-old man with acute myeloid leukaemia (AML) in remission who developed sudden-onset chest pain and shortness of breath 30 min after receiving a blood transfusion. His condition deteriorated and required transferring him to the intensive care unit. The initial differential diagnosis was wide given his immunosuppression, recent chemotherapy, hospitalised status and receipt of blood products. Extensive work up concluded Coxsackie virus-induced myopericarditis as the cause of his symptoms. He was treated with colchicine monotherapy for 3 months and remained without recurrence of pericarditis at 3 months of follow-up. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2015        PMID: 26106180      PMCID: PMC4480108          DOI: 10.1136/bcr-2015-210131

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

Review 1.  Acute pericardial disease: approach to the aetiologic diagnosis.

Authors:  G Permanyer-Miralda
Journal:  Heart       Date:  2004-03       Impact factor: 5.994

Review 2.  Clinical practice. Acute pericarditis.

Authors:  Richard A Lange; L David Hillis
Journal:  N Engl J Med       Date:  2004-11-18       Impact factor: 91.245

3.  Pericarditis induced by high-dose cytosine arabinoside chemotherapy.

Authors:  C Hermans; N Straetmans; J L Michaux; A Ferrant
Journal:  Ann Hematol       Date:  1997 Jul-Aug       Impact factor: 3.673

4.  Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial.

Authors:  Massimo Imazio; Marco Bobbio; Enrico Cecchi; Daniela Demarie; Brunella Demichelis; Franco Pomari; Mauro Moratti; Gianni Gaschino; Massimo Giammaria; Aldo Ghisio; Riccardo Belli; Rita Trinchero
Journal:  Circulation       Date:  2005-09-27       Impact factor: 29.690

5.  Colchicine as first-choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial.

Authors:  Massimo Imazio; Marco Bobbio; Enrico Cecchi; Daniela Demarie; Franco Pomari; Mauro Moratti; Aldo Ghisio; Riccardo Belli; Rita Trinchero
Journal:  Arch Intern Med       Date:  2005-09-26

Review 6.  Pericarditis.

Authors:  Richard W Troughton; Craig R Asher; Allan L Klein
Journal:  Lancet       Date:  2004-02-28       Impact factor: 79.321

7.  Incidence of specific etiology and role of methods for specific etiologic diagnosis of primary acute pericarditis.

Authors:  R Zayas; M Anguita; F Torres; D Giménez; F Bergillos; M Ruiz; M Ciudad; A Gallardo; F Vallés
Journal:  Am J Cardiol       Date:  1995-02-15       Impact factor: 2.778

8.  Clinical profile and influences on outcomes in patients hospitalized for acute pericarditis.

Authors:  Ville Kytö; Jussi Sipilä; Päivi Rautava
Journal:  Circulation       Date:  2014-09-09       Impact factor: 29.690

Review 9.  Cytarabine-induced pericarditis: a case report and review of the literature of the cardio-pulmonary complications of cytarabine therapy.

Authors:  S Reykdal; R Sham; P Kouides
Journal:  Leuk Res       Date:  1995-02       Impact factor: 3.156

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.